SUAKOKO · BONG COUNTY · LIBERIAFaculty room
PHEBENURSE ANESTHESIA

Education with purpose.
Care for Liberia.

How to apply

NANE 103 · WEEK 11 · CLASS 15

Opiate Agonists and Antagonists 1

Guided study notes · January 11–17, 2027

Back to Week 11

Endogenous opioid peptides, receptor subtypes, pain pathways, agonist classifications, structural families, allergy, histamine release, and potency.

Watch this lecture on YouTube

Learning objectives

  • Identify endogenous opioid peptides and major opioid receptor subtypes.
  • Explain how opioids modify ascending and descending pain pathways.
  • Differentiate full agonists, partial agonists, mixed agents, and antagonists.
  • Separate true allergy from predictable effects and histamine-mediated reactions.

Complete the blanks as you watch. Use the time ranges to pause, review and discuss the key ideas with your faculty.

00:00 to 25:00

Reversal Context and Opioid History

  1. Reversal drugs may have a shorter duration than the drug being reversed, creating a risk of ________________.
  2. Opioids were used clinically long before their ________________s and endogenous ligands were identified.
  3. Discovery of opioid ________________s led to identification of endogenous peptides.
  4. Endogenous ________________ systems participate in pain modulation, stress, reward, and other functions.

25:00 to 45:00

Endogenous Peptides and Receptors

  1. Major endogenous opioid peptide families include endorphins, enkephalins, and ________________.
  2. The major ________________ families are mu, kappa, and delta.
  3. Mu receptor activation contributes strongly to analgesia, euphoria, ________________, and physical dependence.
  4. ________________ effects vary with subtype, anatomic location, dose, and drug selectivity.

30:00 to 50:00

Pain Pathways

  1. ________________ signals enter the spinal cord through primary afferent neurons and ascend toward the brain.
  2. ________________s reduce transmitter release presynaptically and hyperpolarize neurons postsynaptically.
  3. Descending pathways from the brainstem can ________________ spinal pain transmission.
  4. ________________ changes pain processing but does not necessarily eliminate the noxious stimulus.

50:00 to 72:00

Agonists Antagonists and Families

  1. A full agonist has high efficacy at its target opioid ________________.
  2. A partial agonist has lower ________________ and may limit the response compared with a full agonist.
  3. A pure antagonist blocks opioid ________________s without providing agonist analgesia.
  4. Structural families help anticipate ________________ but do not perfectly predict allergy.

72:00 to 87:48

Allergy Histamine and Potency

  1. Morphine and some related drugs can release ________________, causing flushing, itching, or hypotension.
  2. ________________ release is not automatically an IgE-mediated allergy.
  3. Potency compares the dose required for a given effect; it does not by itself determine safety or ________________.
  4. Equianalgesic comparison must account for route, incomplete cross-________________, and patient variability.

Notes & questions for class

Lecture recorded in 2017. Use current local protocols and faculty guidance for clinical decisions.